SCHEMBL23772153

SCHEMBL23772153

CC(C)(C)c1ccc(-c2cc(=O)[nH]c(=O)[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.49
ALDH1A1 P00352 3/20 0.47
MITF O75030 1/20 0.47
TP53 P04637 1/20 0.47
KMT2A Q03164 1/20 0.47
NOTUM Q6P988 1/20 0.42
TNKS O95271 5/20 0.41
TNKS2 Q9H2K2 4/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PARP1 P09874 2/20 0.40
SCN5A Q14524 1/20 0.40
GRIN2C Q14957 1/20 0.40
SCN9A Q15858 1/20 0.40
GCGR P47871 1/20 0.40
TAS2R38 P59533 1/20 0.40
CA1 P00915 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
XDH P47989 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20332635 0.83 ALDH1A1 (0.62) GPR84ALDH1A1MITFTP53KMT2A
SCHEMBL3474886 0.75 TAS2R38 (0.66) GPR84ALDH1A1TP53NOTUMKDM4E
SCHEMBL13804844 0.73 TP53 (0.50) ALDH1A1TP53KMT2ANOTUMTNKS2
SCHEMBL31747883 0.72 ALDH1A1 (0.43) ALDH1A1MITFTP53KMT2ANOTUM
SCHEMBL6309811 0.72 KMT2A (0.55) ALDH1A1MITFTP53KMT2ANOTUM
SCHEMBL26846922 0.69 CTSV (0.70) ALDH1A1TP53KMT2AKDM4ELMNA
SCHEMBL31614575 0.69 CTSV (0.70) ALDH1A1TP53KMT2AKDM4ELMNA
SCHEMBL186253 0.68 GCGR (0.47) GPR84ALDH1A1MITFTP53KMT2A
SCHEMBL23758527 0.68 GCGR (0.47) ALDH1A1MITFTP53KMT2AKDM4E
SCHEMBL16414469 0.68 BRD4 (0.61) ALDH1A1MITFTP53KMT2ANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11679093-B2 2-naphthimidamides, analogues thereof, and methods of treatment using same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-06-20 US disclosed
US-20210251942-A1 2-NAPHTHIMIDAMIDES, ANALOGUES THEREOF, AND METHODS OF TREATMENT USING SAME UNIV COLORADO REGENTS (US) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11679093-B2 2-naphthimidamides, analogues thereof, and methods of treatment using same TMPRSS2, TMPRSS4, TMPRSS15 GPR84 1913/4885ALDH1A1 2417/4885MITF 3077/4885
US-20210251942-A1 2-NAPHTHIMIDAMIDES, ANALOGUES THEREOF, AND METHODS OF TREATMENT USING SAME TMPRSS2, TMPRSS4, TMPRSS15 GPR84 1913/4885ALDH1A1 2417/4885MITF 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.